G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 5, 2006, Pages 993-1002

  Zhou, B ^a   Bi, Y Y ^a   Han, Z B ^a,b   Ren, H ^a   Fang, Z H ^a   Yu, X F ^a   Poon, M C ^c   Han, Z C ^a,b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b AmCellGene Co Ltd   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diabetes; Endothelial progenitor cells; Ischemia; Mobilized peripheral blood mononuclear cells; Pericyte recruitment

Indexed keywords

MATRIGEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AMBULATORY MONITORING; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; AUTOTRANSPLANTATION; CAPILLARY DENSITY; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DISEASE SEVERITY; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; LIMB PERFUSION; MALE; MOUSE; NONHUMAN; PERICYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL TRANSPLANTATION; DIABETES MELLITUS; EXTREMITIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 33645635622     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01906.x     Document Type: Article

References (21)

1. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002; 360: 427-35.
2. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, Duriez M, Tobelem G, Levy BI. Impairment in ischemia-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 2004; 164: 457-66.
3. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53:195-9.
4. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-6.
5. Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005; 28: 2155-60.
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
7. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of angiogenesis. Am J Pathol 1998; 152: 1667-79.
8. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109: 1543-9.
9. Takeshita S, Isshiki T, Mori H, Tanaka E, Tanaka A, Umetani K, Eto K, Miyazawa Y, Ochiai M, Sato T. Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats. Cardiovasc Res 1997; 35: 547-52.
10. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-8.
11. Bischoff J. Cell adhesion and angiogenesis. J Clin Invest 1997; 100: S37-9.
12. Phillips DR, Conley PB, Sinha U, Andre P. Therapeutic approaches in arterial thrombosis. J Thromb Haemost 2005; 3: 1577-89.
13. Jansen J, Hanks S, Thompson JM, Dugan MJ, Akard LP. Transplantation of hematopoietic stem cells from the peripheral blood. J Cell Mol Med 2005; 9: 37-50.
14. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106: 571-8.
15. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-36.
16. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, Kojima H, Iwasaka T. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106: 2019-25.
17. Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-9.
18. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
19. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125: 1591-8.
20. Darland DC, D'Amore PA. Blood vessel maturation: Vascular development comes of age. J Clin Invest 1999; 103: 157-8.
21. Saharinen P, Alitalo K. Double target for tumor mass destruction. J Clin Invest 2003; 111: 1277-80.